Health in Argentina

1,099 indicators covering health for Argentina.

IndicatorLatest Year10-yr change Rank
Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th
Percentage of principal display area mandated to be covered by health 50 2022 unchanged 65th
Medical doctors 52.2% 2023 up 15.5% 34th
Number of presumed malaria cases 0 2024 β€” 40th
Contraceptive prevalence, any modern method 56.8% 2020 up 6.3% 8th
Number of indigenous malaria cases 0 2024 β€” 82nd
Number of confirmed malaria cases 26 2024 up 136.4% 89th
Total number ofΒ  malaria cases 26 2024 up 136.4% 89th
Retreatment cases: treatment after default 343 2012 down 8.3% 29th
Yellow fever vaccine (YFV) immunization coverage among 1-year olds 7.0% 2025 up 40.0% 35th
Number of indigenous P. falciparum malaria cases 0 2024 β€” 75th
Number of suspected malaria cases 172 2024 down 95.5% 99th
Retreatment cases: other 497 2012 down 51.7% 39th
Retreatment cases: treatment after failure 8 2012 down 98.0% 94th
Road accident deaths per passenger kilometers 111.1 2017 down 28.0% 4th
Number of malaria positive cases by microscopy 26 2024 up 136.4% 84th
Number of malaria suspects examined by microscopy 172 2024 down 95.5% 96th
Absolute number of deaths from ambient particulate air pollution 16,600 2015 up 7.8% 34th
Natural disasters deaths 4 2021 β€” 6th
Tuberculosis funding versus budget requirement 2.22 million 2025 down 57.2% 53rd
Preterm birth rate 8.86 2020 up 4.2% 26th
Preterm birth 56,354 2020 down 9.8% 27th
Antenatal care attendees who were positive for syphilis (%), reported 6.0% 2023 up 443.4% 4th
Antenatal care coverage - at least four visits 75.3% 2022 down 16.1% 59th
Number of reported deaths from cholera 0 1998 down 100.0% 51st
Number of cases of cutaneous leishmaniasis reported 181 2024 up 31.2% 33rd
Domestic Expenditure on Malaria 0 2024 down 100.0% 75th
Number of cases of visceral leishmaniasis reported 30 2024 up 172.7% 26th
Laboratories providing tuberculosis diagnostic services using culture 14.5 2014 up 12.4% 23rd
Laboratories providing tuberculosis diagnostic services using sputum 1.6 2014 down 11.1% 51st
Congenital syphilis number of cases, reported 1,020 2024 up 3.3% 7th
How many health warnings are approved by the law for smokeless 10 2022 unchanged 12th
Percentage of principal display area mandated to be covered by health 50 2022 unchanged 23rd
Average cost of tuberculosis treatment multi drug resistant 1,547 2024 down 74.2% 31st
Completeness of death registration with cause-of-death information 100.0% 2016 up 0.8% 1st
Congenital syphilis rate per 100 000 live births, reported 221.31 2024 up 74.2% 10th
Nursing personnel 81.6% 2023 up 1.0% 55th
Health worker distribution, by sex and type of occupation 81.6% 2023 up 1.0% 54th
Percentage of principal display area mandated to be covered by health 50 2022 unchanged 23rd
Percentage of principal display area mandated to be covered by health 50 2022 unchanged 23rd
Treatment success rate: XDR-TB cases 25 2022 β€” 74th
Intensive care unit (ICU) beds and use β€” Paediatric intensive care 4.39 Per 100 000 inhabitants 2024 up 8.1% 1st
Participation rate in organized learning (one year before the) 99.4% 2016 up 0.0% 10th
Hpv vaccination coverage in 15 year olds 72 2024 up 14.3% 42nd
Prevalence of syphilis 5.8% 2021 up 432.1% 4th
Sales of beer in 1000s hectolitres 17.69 2009 up 44.0% 91st
Confirmed cases of MDR-TB 63 2012 down 77.2% 51st
New cases: other 143 2012 down 37.8% 12th
Compliance with international health regulations 76 2016 up 13.4% 77th
Number of disruptions to health services attributed to disasters 3 2015 down 93.5% 22nd
Number of indigenous P. vivax malaria cases 0 2024 β€” 39th
Number of imported malaria cases 24 2024 up 118.2% 40th
Number of imported cases of cutaneous leishmaniasis reported 8 2024 up 166.7% 17th
Number of imported cases of visceral leishmaniasis reported 1 2024 down 66.7% 14th
Number of destroyed or damaged health facilities attributed to 2 2009 β€” 23rd
Persistence to last grade of primary 94.0% 2016 up 0.9% 51st
Proportion of bloodstream infection due to Escherichia coli resistant 21.3% 2023 up 16.0% 41st
Antimicrobial resistance or decreased susceptibiity (DS/R) to 6.1 2022 β€” 32nd
Antimicrobial resistance or decreased susceptibiity (DS/R) to 394 2022 up 12.3% 9th
Proportion of bloodstream infection due to methicillin-resistant 35.7% 2023 down 20.6% 23rd